Physician profile
Lori B Colan
NPI 1801885801
$367.30
in general payments reported to CMS, 2019-2025
12 companies · $65.55 in 2025
The $65.55 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.51 · 2020: $33.27 · 2022: $94.68 · 2023: $78.79 · 2024: $46.50 · 2025: $65.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $190.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $77.78 | 2022-2025 | Gardasil 9, Vaxelis, M-M-R II |
| Cranial Technologies, INC | $71.27 | 2019-2025 | Doc Band |
| Alk-Abello, INC | $40.34 | 2023-2024 | Odactra, Ragwitek, Grastek |
| Sobi, INC | $29.60 | 2022 | |
| Boston Scientific Corporation | $27.58 | 2022 | |
| Sanofi-Aventis U.S. LLC | $23.70 | 2025 | |
| Glaxosmithkline, LLC. | $19.29 | 2022 | |
| Phadia US INC. | $19.02 | 2019 | |
| Pfizer INC. | $17.64 | 2020 | |
| Sanofi Pasteur INC. | $15.26 | 2023 | |
| Aytu Biopharma, INC. | $14.99 | 2024 | Karbinal |
| Tris Pharma INC | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Colan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.